Cardinal Health, Inc.
CAH
Clasificación en acciones
#403
Cardinal Health, Inc. operates as a global, integrated provider of healthcare... Cardinal Health, Inc. operates as a global, integrated provider of healthcare services and products, with its reach spanning the United States, Canada, Europe, Asia, and other international markets. The company delivers bespoke support to a diverse clientele, including hospitals, healthcare networks, pharmacies, outpatient surgical centers, clinical labs, physician practices, and individuals receiving care at home. It is structured into two core divisions: Pharmaceutical and Medical. The Pharmaceutical division oversees the distribution of a wide array of products, encompassing branded, generic, and specialty pharmaceuticals, along with over-the-counter health and consumer goods. This segment additionally offers specialized services to pharmaceutical manufacturers and healthcare providers, particularly for specialty pharmaceutical products. Its operations extend to managing nuclear pharmacies and facilities that produce radiopharmaceuticals. It also performs repackaging of generic drugs and OTC items. Further offerings include medication therapy management and patient outcomes services for hospitals, other healthcare providers, and payers, in addition to providing pharmacy management solutions to hospitals. The Medical division focuses on producing, sourcing, and supplying Cardinal Health-branded medical, surgical, and laboratory products and devices. This extensive product range encompasses items such as examination and surgical gloves, needles, syringes, sharps disposal units, compression products, incontinence aids, nutritional delivery systems, wound care supplies, single-use drapes, gowns, and apparel, fluid suction and collection devices, urological products, operating room essentials, and electrodes. Beyond its proprietary brands, this segment also distributes various national brand medical, surgical, and laboratory products. It offers comprehensive supply chain management for hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare organizations, and manufactures and sells both sterile and non-sterile procedure kits. Established in 1979, the company maintains its headquarters in Dublin, Ohio.
Precio por acción
$257.03
Capitalización bursátil
$59.52B
Cambio (1 día)
1.57%
Cambio (1 año)
63.43%
País
US
Comercio Cardinal Health, Inc. (CAH)
Categoría
Healthcare
Ratio P/E de Cardinal Health, Inc. (CAH)
Ratio P/E al October 2026 TTM: 34.08
Según los últimos informes financieros y el precio de las acciones de Cardinal Health, Inc., el P/E actual (TTM) de la empresa es 34.08. Al final de 2024, la empresa tenía un P/E de 28.11.
Historial del ratio P/E de Cardinal Health, Inc. desde 2000 hasta 2026
Relación P/E al final de cada año
| Año | Ratio P/E | Cambiar |
|---|---|---|
| 2026 (TTM) | 34.08 | 31.37% |
| 2025 | 25.94 | -7.74% |
| 2024 | 28.11 | -62.42% |
| 2023 | 74.80 | -581.09% |
| 2022 | -15.55 | -156.98% |
| 2021 | 27.28 | -758.91% |
| 2020 | -4.14 | -139.56% |
| 2019 | 10.47 | -82.47% |
| 2018 | 59.70 | 211.31% |
| 2017 | 19.18 | 7.28% |
| 2016 | 17.88 | -21.79% |
| 2015 | 22.86 | 14.00% |
| 2014 | 20.05 | -58.73% |
| 2013 | 48.59 | 258.45% |
| 2012 | 13.55 | -17.90% |
| 2011 | 16.51 | -12.08% |
| 2010 | 18.78 | 175.63% |
| 2009 | 6.81 | -33.21% |
| 2008 | 10.20 | -1.65% |
| 2007 | 10.37 | -46.68% |
| 2006 | 19.45 | 14.79% |
| 2005 | 16.95 | 16.93% |
| 2004 | 14.49 | -1.16% |
| 2003 | 14.66 | -15.53% |
| 2002 | 17.36 | -33.44% |
| 2001 | 26.08 | 12.25% |
| 2000 | 23.23 | 0.00% |
Relación P/E para empresas similares o competidores
| Empresa | P/E Ratio | Diferencia del P/E Ratio | País |
|---|---|---|---|
| 26.02 | -23.64% |
US
|
|
| - | - |
US
|
|
| - | - |
US
|
|
| 45.62 | 33.86% |
AU
|
|
| 24.73 | -27.43% |
US
|
¿Cómo leer un P/E ratio?
El ratio Precio/Beneficio (P/E Ratio) mide la relación entre el precio de las acciones de una empresa y sus beneficios por acción.
Un P/E bajo pero positivo indica una empresa con altos beneficios en relación a su valoración actual y que podría estar infravalorada. Una empresa con un P/E negativo alto (cerca de 0) indica fuertes pérdidas en comparación con su valoración.
Las empresas con un P/E superior a 30 o negativo suelen considerarse "acciones de crecimiento", lo que significa que los inversores esperan que crezca o se vuelva rentable en el futuro.
Las empresas con un P/E positivo inferior a 10 suelen considerarse "acciones de valor", lo que significa que ya son muy rentables y no se espera un fuerte crecimiento.